Equus Total Return Faces NYSE Delisting Notice as Shares Slip Below $1.00
EQS is trading near its 52-week low of $0.765 (9.8% above the low) on light trading volume (0.1× avg).
Summary
Equus Total Return received an NYSE notice of non-compliance because its average closing price fell below $1.00 over 30 trading days. The company has six months to cure and is considering a reverse stock split.
Key Events · Legal and Risk Events · EQS
-
NYSE Non-Compliance Notice Received
On October 6, 2026, the NYSE notified Equus that its average closing price was below $1.00 over a consecutive 30 trading-day period, violating Section 802.01C.
-
Six-Month Cure Period
Equus must notify the NYSE by October 20, 2026 of its intent to cure and can regain compliance within six months if the closing price and 30-day average both reach at least $1.00.
-
Reverse Stock Split Under Consideration
Management is explicitly evaluating a reverse stock split as a potential remedy to lift the share price above the $1.00 threshold.
-
Existing Debt Defaults Compound Risk
The delisting notice follows previously disclosed defaults on a $2.0 million convertible note and a $3.0 million Morgan E&P loan, heightening liquidity concerns.
Analysis · EQS · Unknown
The NYSE has formally notified Equus Total Return that its average closing price fell below $1.00 over a consecutive 30 trading-day period, triggering a deficiency under Section 802.01C. The company has until October 20, 2026 to notify the exchange of its intent to cure, and a six-month window to regain compliance. Management is explicitly considering a reverse stock split as a remedy. This development arrives amid already disclosed financial distress—the company's $2.0 million convertible note and Morgan E&P's $3.0 million loan were both in default as of the last 10-Q filed August 14, 2026. A delisting would severely impair liquidity and access to capital for a company already under financial pressure.
How filings like this one have moved
In the 30 days to Oct 13, 2026, 44.1% of the 299 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.62%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, EQS was trading at $0.84 on NYSE in the Unknown sector, with a market capitalization of approximately $12.3M. The 52-week trading range was $0.77 to $2.43. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.